Serina Therapeutics Inc.

Penny Stocks Biotech Stocks Healthcare Stocks

$1.94

-0.03 (-1.52%)

As of Jun 30, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +1,303.1% upside

Low Target $16.99

Average Target $27.22

High Target $37.92

Current Price $1.94

Current
$1.94

Target
$27.22

$16.99 $27.22 avg $37.92

Scenario Analysis

Bear Case

$16.99

775.8%

Low target

Base Case

$27.22

+1,303.1%

Avg target

Bull Case

$37.92

+1,854.6%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$7.92

-75.5% from high

52-Week Low

$1.22

+59.0% from low

Target vs 52W High

$27.22

+243.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%